ecNOS overexpression in CsA-treated renal transplant patients:: Implications for CsA-induced hypertension

被引：10
|
作者：
Colò, L
Davis, PA
Rigotti, P
Milani, M
Cantaro, S
Marchini, F
D'Angelo, A
Antonello, A
机构：
[1] Univ Padua, Inst Internal Med, Div Nephrol, I-35128 Padua, Italy
[2] Univ Padua, Div Gen Surg 2, Inst Internal Med, Padua, Italy
[3] Univ Calif Davis, Dept Internal Med, Davis, CA USA
来源：
TRANSPLANTATION PROCEEDINGS | 1998年 / 30卷 / 05期
关键词：
D O I：
10.1016/S0041-1345(98)00514-4
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
下载
收藏
页码：2012 / 2013
页数：2
相关论文
共 50 条
  • [41] Enhanced ATP secretion in platelets from tacrolimus (TACRO) and cyclosporine (CSA)-treated renal transplant recipients (RTR's)
    Salifu, MO
    Markell, MS
    Babinska, A
    Pervez, N
    Kornecki, E
    FASEB JOURNAL, 2000, 14 (04): : A187 - A187
  • [42] EFFECT OF DILTIAZEM (DZM) ON INVITRO LYMPHOCYTE-PROLIFERATION IN CYCLOSPORINE (CSA)-TREATED RENAL-TRANSPLANT RECIPIENTS (RTR)
    KUPIN, W
    SAWAYA, B
    OWNBY, D
    STALLA, K
    KIDNEY INTERNATIONAL, 1990, 37 (01) : 596 - 596
  • [43] No differences in plasma homocysteine (Hcy) levels between cyclosporine (CsA)- or tacrolimus (TAC)- treated renal transplant recipients (RTR)
    Bae, J
    Tolkoff-Rubin, NE
    Baid, S
    Ovuworie, CA
    Williams, WW
    Shih, VE
    Cosimi, AB
    Pascual, MA
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 372A - 372A
  • [44] IMPACT OF INITIAL NONFUNCTION OF THE RENAL-ALLOGRAFT (INF) ON LATER RENAL-FUNCTION IN PATIENTS TREATED WITH CYCLOSPORINE (CSA)
    MONCALIAN, FJ
    FONTAN, MP
    SAAVEDRA, J
    OLIVER, J
    RIVERA, CF
    DAZA, JF
    VALDES, F
    KIDNEY INTERNATIONAL, 1990, 37 (06) : 1602 - 1602
  • [45] Comparative analysis of renal function in patients with cadaveric kidney transplants treated with tacrolimus (TaC) or cyclosporin (CsA).
    Gonzalez-Molina, M
    Morales, JM
    Marcen, R
    Del Castillo, D
    Grinyo, JM
    Gil-Vernet, S
    Oppenheimer, F
    Campistol, JM
    Capdevila, L
    Lampreave, I
    Valdes, F
    Andres, A
    Anaya, F
    Escuin, F
    Arias, M
    Pallardo, L
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 344 - 345
  • [46] Incidence of hyperlipidemia in kidney transplant patients treated with a combination regimen of sirolimus(Rapa)-cyclosporine(CsA)-prednisone(Pred)
    Suri, A
    Kahan, BD
    TRANSPLANTATION, 1999, 67 (07) : S168 - S168
  • [47] ISRADIPINE (ISR) IN THE TREATMENT OF HYPERTENSION IN RENAL-TRANSPLANT PATIENTS (RTP) ON CYCLOSPORINE (CSA) - A RANDOMIZED OPEN-LABEL CROSS-OVER STUDY
    BARRI, YM
    RAMOS, EL
    ORIG, J
    KARLIX, J
    PETERSON, JC
    PARRIS, CJ
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 1072 - 1072
  • [48] Preoperative ATG bolus treatment increase CsA sensitivity of peripheral blood lymphocytes (PBLS) in renal transplant patients
    Abudher, MN
    Moorhead, JF
    Fernando, ON
    Varghese, Z
    TRANSPLANTATION PROCEEDINGS, 1999, 31 (08) : 3361 - 3364
  • [49] Tapering of CSA dose in stable renal transplant patients is safe if monitored by NFAT - Regulated gene expression.
    Sommerer, C
    Giese, T
    Meuer, S
    Zeier, M
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 461 - 461
  • [50] Introduction of mycophenolate mofetil (MMF) and ciclosporine (CSA) withdrawal in heart transplant patients with progressive deteriorating renal function
    Dureau, G
    Obadia, JF
    Chuzel, M
    Boissonnat, P
    TRANSPLANTATION, 1999, 67 (07) : S24 - S24
12345